Get the Stockscreener App
92.52
3.20%
2.87
After Hours:
92.52
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Ventas Inc stock is traded at $92.52, with a volume of 5.45M.
It is up +3.20% in the last 24 hours and up +15.46% over the past month.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
See More
Previous Close:
$89.65
Open:
$90.52
24h Volume:
5.45M
Relative Volume:
1.28
Market Cap:
$44.98B
Revenue:
$6.13B
Net Income/Loss:
$272.21M
P/E Ratio:
167.58
EPS:
0.5521
Net Cash Flow:
$1.38B
1W Performance:
+5.82%
1M Performance:
+15.46%
6M Performance:
+19.64%
1Y Performance:
+47.02%
1-Day Range:
$89.71
$92.86
1-Week Range:
$87.64
$92.86
52-Week Range:
$62.06
$92.86
Ventas Inc Stock (VTR) Company Profile
Name
Ventas Inc
Sector
Industry
Phone
(312) 660-3800
Address
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, DOC, OHI, AHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
92.52 | 43.17B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
236.06 | 160.22B | 11.75B | 1.46B | 2.19B | -0.6014 |
DOC
Healthpeak Properties Inc
|
21.89 | 14.75B | 2.87B | 250.10M | 1.13B | 0.3188 |
OHI
Omega Healthcare Investors Inc
|
49.40 | 14.20B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
55.04 | 10.78B | 2.37B | 101.67M | 169.19M | 0.5775 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | Goldman | Buy |
| Oct-01-25 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-19-25 | Initiated | UBS | Neutral |
| Jun-23-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-07-25 | Upgrade | Argus | Hold → Buy |
| Jan-17-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-01-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-26-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-30-24 | Initiated | Deutsche Bank | Buy |
| Jan-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-07-23 | Upgrade | Wedbush | Neutral → Outperform |
| Oct-11-23 | Initiated | Exane BNP Paribas | Outperform |
| Oct-03-23 | Initiated | Wedbush | Neutral |
| Sep-20-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-11-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-23-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-20-23 | Initiated | Wells Fargo | Overweight |
| Nov-01-22 | Reiterated | Credit Suisse | Outperform |
| Nov-01-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-10-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-30-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-23-22 | Initiated | Credit Suisse | Outperform |
| Jun-03-22 | Initiated | CapitalOne | Overweight |
| May-18-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-11-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Mar-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Feb-01-22 | Initiated | Credit Suisse | Neutral |
| Jan-20-22 | Upgrade | Mizuho | Neutral → Buy |
| Dec-14-21 | Upgrade | Citigroup | Neutral → Buy |
| Nov-22-21 | Downgrade | SMBC Nikko | Outperform → Neutral |
| Oct-04-21 | Resumed | Morgan Stanley | Equal-Weight |
| Sep-23-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-07-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-26-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Jul-14-21 | Resumed | Mizuho | Neutral |
| Jun-15-21 | Initiated | Wolfe Research | Outperform |
| Jun-11-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-13-21 | Upgrade | KeyBanc Capital Markets | Underweight → Overweight |
| May-13-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-08-21 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jan-06-21 | Initiated | Robert W. Baird | Neutral |
| Nov-30-20 | Upgrade | BofA Securities | Underperform → Buy |
| Nov-10-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Argus | Buy → Hold |
| Sep-02-20 | Resumed | Stifel | Hold |
| Aug-20-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-14-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-14-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-15-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Mar-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Mar-23-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Mar-10-20 | Downgrade | Jefferies | Buy → Underperform |
| Feb-28-20 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Jan-22-20 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Jan-17-20 | Upgrade | Jefferies | Hold → Buy |
| Dec-20-19 | Resumed | Mizuho | Neutral |
| Dec-10-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Nov-19-19 | Upgrade | Argus | Hold → Buy |
| Oct-30-19 | Downgrade | Stifel | Buy → Hold |
| Oct-28-19 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Oct-28-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Ventas Inc Stock (VTR) Latest News
Ventas Inc. focuses on senior housing and healthcare real estate - AD HOC NEWS
Evercore ISI Adjusts Ventas Price Target to $96 From $95, Maintains Outperform Rating - marketscreener.com
Louisiana State Employees Retirement System Invests $1.98 Million in Ventas, Inc. $VTR - MarketBeat
Is Ventas stock outperforming the Dow? - MSN
Ventas announces Q2 2026 earnings release date - scanx.trade
Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call - Business Wire
Technical Reactions to VTR Trends in Macro Strategies - Stock Traders Daily
Are You Looking for a High-Growth Dividend Stock? - Yahoo Finance
Ventas Inc To Go Ex-Dividend On June 30th, 2026 With 0.52 USD Dividend Per Share - Moomoo
Ventas adjusts senior leadership, REIT stock in sector focus - AD HOC NEWS
Ventas names head of outpatient medical research property unit - Crain's Chicago Business
Patton Fund Management Inc. Sells 60,624 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas clears S&P 500 healthcare benchmark, shares reflect steady REIT profile - AD HOC NEWS
Chicago REIT Pays $32M for Little Rock Site (Real Deals) - Arkansas Business
The senior housing portfolio from Ventas Inc.stable rents and healthcare demand - AD HOC NEWS
Price to earnings forward of Ventas, Inc. – BOATS:VTR - TradingView
Ventas, Inc.(NYSE: VTR) added to Russell 1000 Defensive Index - marketscreener.com
Is Ventas (VTR) Rewriting Its Risk Profile With New Outpatient Leadership And Interim Legal Steward? - Sahm
Ventas opens the week with a strategy focus, shares in the US healthcare REIT sector - Ad-hoc-news.de
Union Bancaire Privee UBP SA Acquires 33,030 Shares of Ventas, Inc. $VTR - MarketBeat
Sterling Capital Management LLC Cuts Holdings in Ventas, Inc. $VTR - MarketBeat
Ventas opens the weekend with a clear strategy focus, shares on the NYSE radar - Ad-hoc-news.de
46,134 Shares in Ventas, Inc. $VTR Purchased by OP Asset Management Ltd - MarketBeat
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventyx Biosciences clarifies pipeline strategy, shares react to sector volatility - Ad-hoc-news.de
Ventas Inc. highlights senior housing growth, REIT shares in S&P 500 focus - Ad-hoc-news.de
Ventas updates its senior notes filing, REIT stock under investor scrutiny - Ad-hoc-news.de
Ventas (VTR) Citi’s Miami Global Property CEO Conference 2026 Summary - Quartr
Ventas, Inc. Actuals & Estimates (NYSE:VTR) - TradingView
Ventas, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh Actuals & Estimates (BMFBOVESPA:V1TA34) - TradingView
Price to sales forward of Ventas, Inc. – NYSE:VTR - TradingView
Enterprise value to EBIT forward of Ventas, Inc. – NYSE:VTR - TradingView
Enterprise value to revenue forward of Ventas, Inc. – NYSE:VTR - TradingView
Ventas, Inc. Actuals & Estimates (BX:VEN) - TradingView
Is Holding Ventas Stock Still a Smart Move for Your Portfolio Now? - TradingView
Ventas Inc. updates leadership in outpatient medical properties, shares in S&P 500 healthcare real e - Ad-hoc-news.de
VTR Forecast — Price Target — Prediction for 2027 - TradingView
Friedenthal Financial Acquires Shares of 11,847 Ventas, Inc. $VTR - MarketBeat
SG Americas Securities LLC Has $25.48 Million Position in Ventas, Inc. $VTR - MarketBeat
Ventas Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Ventas announces leadership change in outpatient platform, shares in S&P 500 healthcare REIT focus - Ad-hoc-news.de
Ventas Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
The Senior Living Communities from Ventas Inc.healthcare real estate that runs quietly in the bac - Ad-hoc-news.de
Ventas Appoints Andrew L. Wattula as Executive Vice President of Outpatient Medical and Research - geneonline.com
Ventas, Inc. Announces Appointment of Andrew L. Wattula as Executive Vice President, Outpatient Medical & Research, Effective August 2026 - marketscreener.com
Diversified Trust Co Purchases 32,436 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas StockAnalyst consensus and dividend profile in focus - AD HOC NEWS
Ventas taps Hudson Pacific COO to run medical research properties - Stock Titan
World Investment Advisors Invests $1.91 Million in Ventas, Inc. $VTR - MarketBeat
Hsbc Holdings PLC Grows Stock Holdings in Ventas, Inc. $VTR - MarketBeat
Groupama Asset Managment Lowers Holdings in Ventas, Inc. $VTR - MarketBeat
Ventas Inc Stock (VTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):